this paper discusses the pharmaceutical compositions containing \u0438\u0431\u0440\u0443\u0442\u0438\u043d\u0438\u0431 and how to obtain them.these compositions can be used in the treatment of various conditions, including, without limitation, in the - cell \u043f\u0440\u043e\u043b\u0438\u0444\u0435\u0440\u0430\u0442\u0438\u0432\u043d\u044b\u0435 disordersuch as non hodgkins lymphoma (diffuse in \u043a\u0440\u0443\u043f\u043d\u043e\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u0430\u044f \u0444\u043e\u043b\u043b\u0438\u043a\u0443\u043b\u044f\u0440\u043d\u0430\u044f lymphoma, lymphoma, lymphoma of the cells \u043c\u0430\u043d\u0442\u0438\u0439\u043d\u043e\u0439 zone or burkitts lymphoma), \u043c\u0430\u043a\u0440\u043e\u0433\u043b\u043e\u0431\u0443\u043b\u0438 \u043d\u0435\u043c\u0438\u044e \u0432\u0430\u043b\u044c\u0434\u0435\u043d\u0441\u0442\u0440\u0435\u043c\u0430,\u043f\u043b\u0430\u0437\u043c\u0430\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u0443\u044e myeloma, chronic lymphocytic leukemia, lymphoma or leukemia. these compositions are intended for ingestion.the composition is contained within the capsule, such as a standard or \u0432\u0441\u043a\u0440\u044b\u0432\u0430\u0435\u043c\u0430\u044f capsule or in the liquid composition, such as a suspension.in one version of the pharmaceutical composition contains \u0438\u0431\u0440\u0443\u0442\u0438\u043d\u0438\u0431, its salt, or a metabolite \u043f\u0440\u043e\u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u043e, microcrystalline cellulose, \u043a\u0440\u043e\u0441\u043a\u0430\u0440\u043c\u0438\u0435 \u043b\u0438\u043e\u0437\u0443 sodiumsodium dodecyl sulfate and magnesium \u0441\u0442\u0435\u0430\u0440\u0430\u0442.in another version, the pharmaceutical composition contains \u0438\u0431\u0440\u0443\u0442\u0438\u043d\u0438\u0431, its salt, or a metabolite \u043f\u0440\u043e\u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u043e, microcrystalline cellulose, sodium salt \u043a\u0430\u0440\u0431\u043e\u043a\u0441\u0438\u04
